Product image of Metilfenidato Generis (Methylphenidate Hydrochloride) supplied by GNH India

Metilfenidato Generis

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Metilfenidato Generis (Methylphenidate Hydrochloride)

Methylphenidate Hydrochloride, the active ingredient in Metilfenidato Generis, is a central nervous system stimulant presented as an oral tablet for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults, improving focus, reducing impulsivity, and promoting wakefulness by enhancing neurotransmitter activity.

GNH India supplies Metilfenidato Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality manufacturing standards and reliable distribution across global markets. The company adheres to EU regulations and rigorous quality control procedures.

Manufacturer / TM Owner

Generis Farmacêutica, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylphenidate Hydrochloride is indicated for conditions within the central nervous system stimulant therapeutic class.

  • Attention deficit hyperactivity disorder (ADHD): improves attention, reduces hyperactivity and impulsivity in children, adolescents, and adults.
  • Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.
  • ADHD in adults: enhances executive function and reduces distractibility.

How It Works

  • Methylphenidate Hydrochloride acts primarily by blocking the dopamine transporter (DAT) and the norepinephrine transporter (NET), which inhibits the reuptake of dopamine and norepinephrine into presynaptic neurons. This results in increased concentrations of these catecholamines in the synaptic cleft, enhancing neurotransmission in brain regions that regulate attention, impulse control, and arousal. The heightened catecholamine activity modulates cortical and subcortical circuits involved in executive function and sleep regulation.

Side Effects

Methylphenidate Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Insomnia: difficulty falling or staying asleep.
  • Decreased appetite: reduced hunger leading to weight loss.
  • Headache: mild to moderate cranial pain.
  • Stomach upset: nausea or abdominal discomfort.

Serious or Rare Side Effects

  • Cardiovascular events: hypertension, tachycardia, or arrhythmia.
  • Psychosis or severe mood changes: hallucinations, delusions, or manic episodes.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.

Precautions & Warnings

When prescribing methylphenidate, clinicians should consider several safety precautions to minimize risk.

  • Cardiovascular assessment: evaluate heart disease and blood pressure before initiating therapy.
  • Psychiatric history: monitor for mood swings, anxiety, or emergence of psychotic symptoms.
  • Growth monitoring in children: regularly track height and weight during treatment.
  • Potential for abuse: use only when clearly indicated and monitor for misuse.
  • Drug interactions: review concomitant medications for possible interactions.
  • Store at ambient temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Methylphenidate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Tricyclic antidepressants: may increase cardiovascular side effects.
  • Antihypertensive agents: methylphenidate may reduce their blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely)

  • Selective serotonin reuptake inhibitors (SSRIs) and serotonin‑norepinephrine reuptake inhibitors (SNRIs): may increase risk of serotonin syndrome.
  • Antacids: can alter absorption, requiring dose timing adjustments.

Frequently Asked Questions

Metilfenidato Generis, containing methylphenidate hydrochloride, is prescribed for attention deficit hyperactivity disorder (ADHD) and for narcolepsy. In ADHD it helps improve focus, reduce hyperactivity and impulsivity, while in narcolepsy it lessens excessive daytime sleepiness and supports wakefulness.

Methylphenidate hydrochloride blocks the reuptake of dopamine and norepinephrine by inhibiting their transporters. This increases the concentration of these neurotransmitters in the synaptic cleft, enhancing signaling in brain pathways that control attention, impulse control, and arousal.

The appropriate dose of Metilfenidato Generis is individualized by the prescribing clinician based on the patient’s age, weight, severity of symptoms, and response to therapy. Dosage adjustments are made during follow‑up visits to achieve optimal benefit while minimizing side effects.

Safety data for methylphenidate during pregnancy and lactation are limited, and the product is classified with an unknown pregnancy category. Clinicians should weigh potential benefits against risks and consider alternative treatments when treating pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metilfenidato Generis belongs to the central nervous system stimulant class, similar to other methylphenidate products and amphetamine‑based agents. Compared with non‑stimulant options, it generally has a faster onset of action but may carry a higher risk of cardiovascular and psychiatric side effects, requiring careful monitoring.

Store Metilfenidato Generis at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Metilfenidato Generis is taken orally, usually as a tablet, and should be swallowed whole with water. The prescribing physician determines the timing and frequency, which may be once or multiple times per day depending on the therapeutic plan.

The most serious risks include cardiovascular complications such as hypertension or arrhythmia, severe psychiatric events like psychosis or mania, and rare but life‑threatening allergic reactions (anaphylaxis). Patients should be monitored closely for these events, especially during treatment initiation.

Metilfenidato Generis is contraindicated in individuals with known hypersensitivity to methylphenidate, those taking monoamine oxidase inhibitors, patients with severe cardiovascular disease, and persons with a history of psychosis or severe anxiety disorders unless specifically advised by a specialist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT